Velocity Bio
San Carlos
About Velocity Bio
Velocity Bio is a Stanford University spinout developing high-throughput platforms capable of selectivity-first allosteric drug discovery for under-drugged human enzymes implicated in devastating diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Oct 2024)
- Website: velocitybio.tech
Industries & Categories
Biotechnology, Life Science, Product Research
Social Profiles
Canonical: https://fsome.com/organization/velocity-bio-2242909 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.